Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Updates?

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Dec 09, 2020 10:54pm

236 Views

Post# 32074345

RE:RE:RE:RE:Updates?

Works on enveloped viruses. How many different viruses can TLD-1433 be effective for? SARS-Cov, Influenza, Ebola, Zika ? These are all enveloped viruses. The potential could be huge here, but I do think they should only proceed with Grant money, or a Big Pharma partner for this. They should focus on NMIBC first, then MIBC, GBM and NSCLC etc. Dr Coombs must be well connected, if he sees something worthy he will get it to trials IMO.

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta